EXPERIMENTAL CONFIRMATION FOR SELECTION OF IRRADIATION REGIMENS FOR INTRAPERITONEAL PHOTODYNAMIC THERAPY WITH PORPHYRIN AND PHTHALOCYANINE PHOTOSENSITIZERS

Optimized irradiation regimens for intraperitoneal photodynamic therapy with porphyrin and phthalocyanine photosensitizers are determined in in vitro and in vivo studies.

The experimental  study on НЕр2 cell line showed that reduce of power density for constant  light dose increased significantly the efficacy of photodynamic therapy (the reduce of power density from 20-80 mW/cm² to 10 mW/cm² had the same results (90% cell death) for half as much concentration of the photosensitizer).

The obtained results were confirmed in vivo in mice with grafted tumor S-37. For light dose of 90 J/cm²  and power density of 25 mW/cm² none of animals in the experimental  group had total resorption of the tumor. For the same light dose and decrease  of power density to 12 mW/cm²  total tumor resorption was achieved in 34% of animals, 66% of animals died from phototoxic  shock. For twofold decrease  of light dose – to 45 J/cm²  with the same low-intensity power density (12 mW/cm²) we managed total tumor resorption in 100% of animals.

In the following studies of optimized irradiation regimen for intrapleural photodynamic therapy the reaction of intact peritoneum of rats on photodynamic exposure was assessed and optimized parameters of laser irradiation, which did not cause necrosis and intense inflammatory reaction of peritoneum, were determined – light dose of 10 J/cm²  with power density of mW/cm².

Thus, the reasonability for use of low-intensity regimens of irradiation for intraperitoneal photodynamic therapy was confirmed experimentally with possibility of high efficacy of treatment without inflammatory reactions of peritoneum.

1. ChissovV.I., SokolovV.V., Filonenko E.V. Photodynamic therapy of malignant tumors. A brief history of development and clinical use in Russia, Rossiiskii khimicheskii zhurnal, 1998, Vol. XLII, No. 5, pp. 5-9. (in Russian).

2. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., Korbelik M., Moan J., Mroz P., Nowis D., Piette J., Wilson B.C., Golab J. Photodynamic therapy of cancer: an update, CA Cancer J Clin., 2011, Vol. 61, No. 4, pp. 250-281.

3. Dougherty T.J., Marcus S.L. Photodynamic therapy, Eur J Cancer, 1992, Vol. 28A, No. 10, pp. 1734-1742.

4. Sokolov V.V., Filonenko E.V., Karpova E.S., Mamontov A.S. Opportunities of photodynamic therapy of patients with esophageal cancer stage T1N0M0: case report, Rossiiskii onkologicheskii zhurnal, 2007, No. 6, pp. 36-38. (in Russian).

5. Filonenko E.V., Vashakmadze L.A., Kirillov N.V., Khomyakov V.M., Kolobaev I.V., Krylova G.I. Intraoperative photodynamic therapy for locally advanced and disseminated gastric cancer, Onkokhirurgiya, 2012,Vol. 4, No. 3, pp. 57-61. (in Russian).

6. Ivanova-Radkevich V.I., Filonenko E.V., Slovokhodov E.K., Smirnova I.P., Kuznetsova O.M., Lobaeva T.A., Gushchina Yu.Sh. and Khadasheva Z.S. Organization of clinical trials of photosensitizer based on 5-aminolevulinic acid hexyl ester, Indian Journal of Science and Technology, 2016, Vol. 9(18), pp. 1-7. DOI: 10.17485/ijst/2016/v9i18/93759

7. Filonenko E.V., Kaprin A.D., Alekseev B.Ya., Apolikhin O.I., Slovokhodov E.K., Ivanova-Radkevich V.I., Urlova A.N. 5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial), Photodiagnosis and Photodynamic Therapy, 2016, Vol. 16, pp. 106-109.

8. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv. Chast' 1 [Handbook for management of pre-clinical studies of pharmaceutical preparations. Part 1], by eds Mironov A.N., Butanyan N.D. Мoscow, Grif i K. Publ., 2012. 944 p.